Leukemia inhibitory factor (LIF) is a multi-functional cytokine of the interleukin-6 (IL-6)
superfamily. Initially identified as a factor that inhibits the proliferation of murine myeloid …

Leukemia inhibitory factor (LIF) is a pleiotropic cytokine of the interleukin-6 (IL-6)
superfamily. LIF was initially discovered as a factor to induce the differentiation of myeloid …

Leukemia Inhibitory Factor (LIF) is a member of the IL-6 cytokine family and is expressed in
almost every tissue type within the body. Although LIF was named for its ability to induce …

Tumorigenesis and metastasis have deep connections to inflammation and inflammatory
cytokines, but the mechanisms underlying these relationships are poorly understood …

Gastric cancer predominantly occurs in adenocarcinoma form and is characterized by
uncontrolled growth and metastases of gastric epithelial cells. The growth of gastric cells is …

The dysregulation of leukemia inhibitory factor (LIF) and its cognate receptor (LIFR) has
been associated with multiple cancer initiation, progression, and metastasis. LIF plays a …

Cancer stem cells (CSCs) present chemo-resistance mechanisms contributing to tumour
maintenance and recurrence, making their targeting of utmost importance in gastric cancer …

Abstract Bone morphogenetic protein 1 (BMP1) is a secreted metalloprotease of the astacin
M12A family of bone morphogenetic proteins (BMPs). BMP1 activates transforming growth …

Chemotherapy is the preferred clinical treatment for advanced stage gastric cancer (GC)
patients, of which efficacy could be markedly impaired due to the development of …

Aims The most frequent cancers among women worldwide. The mortality of cervical cancer
has declined significantly primarily due to the widespread use of Pap smear tests as a …